Skip to Main Content

Author Details

Nadia Boufaied
Research Institute of the McGill University Health Centre
2000
17
10
PMIDPaper TitleJournal TitlePublished Year
36765862SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation.Cancers (Basel)2023
37552602CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis.Cell Rep2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
35562350MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.Nat Commun2022
35603787Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome.JCI Insight2022
34493786CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosis.Commun Biol2021
33899001EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.Nat Cancer2021
31206668Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.J Pathol2019
31723159Characterization of Matricellular Protein Expression Signatures in Mechanistically Diverse Mouse Models of Kidney Injury.Sci Rep2019
31350272Genome-wide analysis of androgen receptor binding and transcriptomic analysis in mesenchymal subsets during prostate development.Dis Model Mech2019
28483704Genome-wide analysis of AR binding and comparison with transcript expression in primary human fetal prostate fibroblasts and cancer associated fibroblasts.Mol Cell Endocrinol2018
29180763Identification of genes expressed in a mesenchymal subset regulating prostate organogenesis using tissue and single cell transcriptomics.Sci Rep2017
28152543Asporin is a stromally expressed marker associated with prostate cancer progression.Br J Cancer2017
20220516TLN-4601, a novel anticancer agent, inhibits Ras signaling post Ras prenylation and before MEK activation.Anticancer Drugs2010
21044336TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling.J Mol Signal2010
16460236High levels of oxidative stress globally inhibit gene transcription and histone acetylation.DNA Cell Biol2006
11256609BRCA1 can stimulate gene transcription by a unique mechanism.EMBO Rep2000
  • 1 - 17 of 17

Recommended Authors

Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 3
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 8
Xinpei Ci
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 7
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 7
Estelle Li
University of British Columbia
Career Start Year 2012
Number of shared co-authors 7
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 19
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 12
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 12
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 5
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 15
Alfonso Urbanucci
Northwestern University Feinberg School of Medicine Chicago
Career Start Year 2008
Number of shared co-authors 13
Alastair Davies
University of British Columbia
Career Start Year 2008
Number of shared co-authors 4
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 8
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 3
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 3
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 5
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 5
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 11
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 29
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 21
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 6
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 19
Leena Latonen
Foundation for the Finnish Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Kristiina Iljin
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 8
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 9
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 15
Guido Jenster
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 9

Collaborators

Matthew L Freedman
Dana-Farber Cancer Institute
Co-authored papers 3
Mark M Pomerantz
Dana-Farber Cancer Institute
Co-authored papers 3
Leigh Ellis
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 2
Eva Corey
University of Washington School of Medicine
Co-authored papers 2
Karl-Philippe Gu??rard
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 2
Elai Davicioni
Veracyte Inc.
Co-authored papers 2
Edward O'Connor
Dana-Farber Cancer Institute
Co-authored papers 2
Armen Aprikian
McGill University Health Centre, McGill University
Co-authored papers 2
Massimo Loda
Weill Medical College of Cornell University
Co-authored papers 2
Eleonora Scarlata
Research Institute of the McGill University Health Center (RI-MUHC)
Co-authored papers 2
Connor Bell
Dana-Farber Cancer Institute
Co-authored papers 2
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers 2
Myles Brown
Co-authored papers 2
Ian G Mills
Queen's University Belfast
Co-authored papers 1
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 1
A Thomson
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 1
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 1
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 1
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 1
Glenn Bauman
Western University and London Regional Cancer Program
Co-authored papers 1
Shawn M Chevalier
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 1
David M Berman
Queen's University
Co-authored papers 1
Simone Chevalier
McGill University Health Centre, McGill University
Co-authored papers 1
Fred Saad
University of Montreal Health Center
Co-authored papers 1
Adam G Sowalsky
National Cancer Institute
Co-authored papers 1
Ralph Buttyan
University of British Columbia
Co-authored papers 1
Yang Liu
Veracyte inc.
Co-authored papers 1
R Jeffrey Karnes
Mayo Clinic
Co-authored papers 1
Anjali V Sheahan
Dana-Farber Cancer Institute
Co-authored papers 1
Sheila Weinmann
Center for Health Research, Kaiser Permanente Northwest Research Center
Co-authored papers 1
Release 1.2